# Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)

> **NCT02741271** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 181 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** MF MDI 100 mcg BID (Open Label)
- **DRUG:** MF/F MDI 100/10 mcg BID
- **DRUG:** MF MDI 100 mcg BID
- **DRUG:** Albuterol/Salbutamol PRN
- **DRUG:** Prednisone/Prednisolone

## Key facts

- **NCT ID:** NCT02741271
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-11
- **Primary completion:** 2017-12-04
- **Final completion:** 2017-12-04
- **Target enrollment:** 181 (ACTUAL)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02741271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02741271, "Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02741271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*